Bioadaptives annual revenue
2019
2020
2021
2022
2023
2024
2025
Bioadaptives Revenue Growth & History (BDPT)
Bioadaptives reported $18,278 in revenue for fiscal 2025, an increase of 44.27% from the previous fiscal year.
View full Bioadaptives company overviewBioadaptives annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $18,278 | $5,609 | +44.27% |
| 2024 | 2024-12-31 | $12,669 | −$15,896 | −55.65% |
| 2023 | 2023-12-31 | $28,565 | $11,389 | +66.31% |
| 2022 | 2022-12-31 | $17,176 | −$2,600 | −13.15% |
| 2021 | 2021-12-31 | $19,776 | $3,449 | +21.12% |
| 2020 | 2020-12-31 | $16,327 | $6,393 | +64.35% |
| 2019 | 2019-12-31 | $9,934 | — | — |
Bioadaptives quarterly revenue
Q3.16
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4,988 | $1,769 | +54.95% |
| Q1 2026 | 2026-03-31 | $5,514 | $5,514 | — |
| Q4 2025 | 2025-12-31 | $10,427 | $10,427 | — |
| Q3 2025 | 2025-09-30 | $4,632 | $4,632 | — |
| Q2 2025 | 2025-06-30 | $3,219 | $2,544 | +376.89% |
| Q1 2025 | 2025-03-31 | $0 | −$11,994 | −100.00% |
| Q4 2024 | 2024-12-31 | $0 | −$7,201 | −100.00% |
| Q3 2024 | 2024-09-30 | $0 | −$15,649 | −100.00% |
| Q2 2024 | 2024-06-30 | $675 | −$1,664 | −71.14% |
| Q1 2024 | 2024-03-31 | $11,994 | $8,618 | +255.27% |
| Q4 2023 | 2023-12-31 | $7,201 | $3,217 | +80.75% |
| Q3 2023 | 2023-09-30 | $15,649 | $12,312 | +368.95% |
| Q2 2023 | 2023-06-30 | $2,339 | −$1,983 | −45.88% |
| Q1 2023 | 2023-03-31 | $3,376 | −$2,157 | −38.98% |
| Q4 2022 | 2022-12-31 | $3,984 | $133 | +3.45% |
| Q3 2022 | 2022-09-30 | $3,337 | −$2,005 | −37.53% |
| Q2 2022 | 2022-06-30 | $4,322 | −$1,743 | −28.74% |
| Q1 2022 | 2022-03-31 | $5,533 | $1,015 | +22.47% |
| Q4 2021 | 2021-12-31 | $3,851 | $120 | +3.22% |
| Q3 2021 | 2021-09-30 | $5,342 | $903 | +20.34% |
| Q2 2021 | 2021-06-30 | $6,065 | $2,563 | +73.19% |
| Q1 2021 | 2021-03-31 | $4,518 | −$137 | −2.94% |
| Q4 2020 | 2020-12-31 | $3,731 | $2,576 | +223.03% |
| Q3 2020 | 2020-09-30 | $4,439 | $2,363 | +113.82% |
| Q2 2020 | 2020-06-30 | $3,502 | −$1,669 | −32.28% |
| Q1 2020 | 2020-03-31 | $4,655 | $3,123 | +203.85% |
| Q4 2019 | 2019-12-31 | $1,155 | — | — |
| Q3 2019 | 2019-09-30 | $2,076 | — | — |
| Q2 2019 | 2019-06-30 | $5,171 | — | — |
| Q1 2019 | 2019-03-31 | $1,532 | — | — |
| Q3 2016 | 2016-09-30 | $11,944 | — | — |
Bioadaptives revenue growth trends
Over the last five reported fiscal years, revenue grew from $16,327 to $18,278, a compound annual growth rate of 2.28%. Bioadaptives's latest reported quarter, Q2 2026, generated $4,988 in revenue, an increase of 54.95% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Bioadaptives source filings ↗